Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma – results from the National Swedish Kidney Cancer Register

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Harmenberg U, Lindblad P, et al. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma. Scand J Urol. 2016;50(1):2–8.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399–410. Epub ahead of print. PMID: 35346519.
   PubMed Web of Science ®Google Scholar
• Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–529.
   PubMed Web of Science ®Google Scholar
• Weight CJ, Lythgoe C, Unnikrishnan R, et al. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology. 2011;77(5):1142–1146.
   PubMed Web of Science ®Google Scholar
• Deng H, Fan Y, Yuan F, et al. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: a meta-analysis. Int Braz J Urol. 2021;47(1):46–60.
   PubMed Web of Science ®Google Scholar
• Dabestani S, Thorstenson A, Lindblad P, et al. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34(8):1081–1086.
   PubMed Web of Science ®Google Scholar
• Ramaswamy K, Kheterpal E, Pham H, et al. Significance of pathologic T3a upstaging in clinical T1 renal masses undergoing nephrectomy. Clin Genitourin Cancer. 2015;13(4):344–349.
   PubMed Web of Science ®Google Scholar
• Nayak JG, Patel P, Saarela O, et al. Pathological upstaging of clinical T1 to pathological T3a renal cell carcinoma: a multi-institutional analysis of short-term outcomes. Urology. 2016;94:154–160.
   PubMed Web of Science ®Google Scholar
• Almdalal T, Sundqvist P, Harmenberg U, et al. Clinical T1a renal cell carcinoma, not always harmless – a national register study. Eur Urol Open Sci. 2022;39:22–28.
   PubMedGoogle Scholar
• Sobin LH, Gospodarowicz MK, Wittekind C, editors. 2009. TNM classification of malignant tumours. 7th ed. New York: Wiley-Liss.
   Google Scholar
• Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105.
   PubMed Web of Science ®Google Scholar
• Patel SH, Uzzo RG, Larcher A, et al. Oncologic and functional outcomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma: a multi-institutional analysis. Clin Genitourin Cancer. 2020;18(6):e723–e729.
   PubMed Web of Science ®Google Scholar
• Veccia A, Falagario U, Martini A, et al. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: a systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus. 2021;7(3):574–581.
   PubMedGoogle Scholar
• Chevinsky M, Imnadze M, Sankin A, et al. Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma. J Urol. 2015;194(2):310–315.
   PubMed Web of Science ®Google Scholar
• Teishima J, Hayashi T, Kitano H, et al. Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3. Jpn J Clin Oncol. 2020;50(4):473–478.
   PubMed Web of Science ®Google Scholar
• Renard AS, Nedelcu C, Paisant A, et al. Is multidetector CT-scan able to detect T3a renal tumor before surgery? Scand J Urol. 2019;53(5):350–355.
   PubMed Web of Science ®Google Scholar
• Kim SH, Park B, Hwang EC, et al. Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy. Sci Rep. 2021;11(1):3079.
   PubMed Web of Science ®Google Scholar
• Noguchi G, Nakaigawa N, Taguri M, et al. Time-dependent change in relapse sites of renal cell carcinoma after curative surgery. Clin Exp Metastasis. 2018;35(1–2):69–75.
   PubMed Web of Science ®Google Scholar
• Abu-Ghanem Y, Powles T, Capitanio U, et al. The impact of histological subtype on the incidence, timing, and patterns of recurrence in patients with renal cell carcinoma after surgery-results from RECUR consortium. Eur Urol Oncol. 2021;4(3):473–482.
   PubMed Web of Science ®Google Scholar
• Jiang K, Tang K, Guo X, et al. Laparoscopic cryoablation vs. percutaneous cryoablation for treatment of small renal masses: a systematic review and meta-analysis. Oncotarget. 2017;8(16):27635–27644.
   PubMedGoogle Scholar
• Abu-Ghanem Y, Fernández-Pello S, Bex A, et al. Limitations of available studies prevent reliable comparison between tumour ablation and partial nephrectomy for patients with localised renal masses: a systematic review from the European Association of Urology Renal Cell Cancer Guideline Panel. Eur Urol Oncol. 2020;3(4):433–452.
   PubMed Web of Science ®Google Scholar
• MacLennan S, Imamura M, Lapitan MC, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012;62(6):1097–1117.
   PubMed Web of Science ®Google Scholar
• Correa AF, Toussi A, Amin M, et al. Small renal masses in close proximity to the collecting system and renal sinus are enriched for malignancy and high fuhrman grade and should be considered for early intervention. Clin Genitourin Cancer. 2018;16(4):e729–e733.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Hedin O, Lundstam S, et al. Nephron sparing surgery associated with better survival than radical nephrectomy in patients treated for unforeseen benign renal tumors. Urology. 2016;93:117–123.
   PubMed Web of Science ®Google Scholar
• Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–740.
   PubMed Web of Science ®Google Scholar
• Kates M, Badalato GM, Pitman M, et al. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol. 2011;186(4):1247–1253.
   PubMed Web of Science ®Google Scholar
• Sun M, Becker A, Tian Z, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. 2014;65(1):235–241.
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59(4):543–552.
   PubMed Web of Science ®Google Scholar
• Chung DY, Kang DH, Kim JW, et al. Comparison of oncologic outcomes between partial nephrectomy and radical nephrectomy in patients who were upstaged from cT1 renal tumor to pT3a renal cell carcinoma: an updated systematic review and meta-analysis. Ther Adv Urol. 2020;12:1756287220981508.
   Web of Science ®Google Scholar
• Tang Y, Liu F, Mao X, et al. The impact of tumor size on the survival of patients with small renal masses: a population-based study. Cancer Med. 2022;11(12):2377–2385.
   PubMed Web of Science ®Google Scholar
• Larcher A, Capitanio U, Terrone C, et al. Elective nephron sparing surgery decreases other cause mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol. 2016;196(4):1008–1013.
   PubMed Web of Science ®Google Scholar
• Landberg A, Bruce D, Lindblad P, et al. Validation of data quality in the National Swedish Kidney Cancer Register. Scand J Urol. 2021;18:1–7.
   Google Scholar